More than half (74%) of these variants (germline = 33, somatic = 22) have been previously reported in a DDX41-mutated hematologic malignancy or were seen in more than one DDX41 mutated patient from this study cohort (Table 1, Figure 1). The gene discussed is DDX41; the disease is hematologic disorder.